Noel T. Brewer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Noel T. Brewer has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alrick S. Edwards
University of North Carolina, Chapel Hill, NC
2 shared publicationsBarbara K. Rimer
University of North Carolina, Chapel Hill, NC
2 shared publicationsJanice P. Tzeng
University of North Carolina, Chapel Hill, NC
2 shared publications- Sarah E. Lillie
Minneapolis VA Health Care System, USA
2 shared publications Jeffrey M. Peppercorn
University of North Carolina, Chapel Hill, NC
1 shared publicationLisa A. Carey
University of North Carolina
1 shared publication
Latest Publications
- 1 November 2008
- Published by Elsevier in Preventive Medicine
- Vol. 47 (5) , 483-484
Assessing and increasing breast cancer screening
- 1 November 2008
- Published by Elsevier in Preventive Medicine
- Vol. 47 (5) , 483-484
Assessing and increasing breast cancer screening
- 3 October 2008
- Published by SAGE Publications in Medical Decision Making
- Vol. 29 (2) , 157-166
Health Literacy and Cancer Risk Perception: Implications for Genomic Risk Communication
Background. As new genomic technology expands the number of medical tests available to physicians and patients, identifying gaps in our understanding of how best to communicate risk is increasingly important. We examined how health literacy informs breast cancer survivors' understanding of and meaning assigned to recurrence risks yielded by genomic tests. Methods. Study participants were posttreatment female breast cancer survivors (N =163) recruited at a university breast cancer clinic. We assessed their health literacy (using REALM) and their interpretation of hypothetical recurrence risk results from a genomic test, presented in several verbal and numerical formats. Analyses controlled for women's objective recurrence risk, age, income, and race. Results. Women with lower health literacy gave higher mean estimates of recurrence risk for a hypothetical group of women with early-stage breast cancer than did women with higher health literacy (52% v. 30%, P < 0:001). Women with lower health literacy also gave more variable estimates in this and several other tasks. When making chemotherapy decisions using risks presented in verbal formats, decisions by women with lower health literacy were less sensitive to the difference between low and high recurrence risk. Ease of understanding of risk formats differed by health literacy. Conclusions. Health literacy affected the meanings women assigned to recurrence risk when presented in certain formats. The greater variability in responding by women with lower health literacy supports the hypothesis that they have less precise mental representations of risk, but more research is needed to rule out other possible explanations.
- 3 October 2008
- Published by SAGE Publications in Medical Decision Making
- Vol. 29 (2) , 157-166
Health Literacy and Cancer Risk Perception: Implications for Genomic Risk Communication
Background. As new genomic technology expands the number of medical tests available to physicians and patients, identifying gaps in our understanding of how best to communicate risk is increasingly important. We examined how health literacy informs breast cancer survivors' understanding of and meaning assigned to recurrence risks yielded by genomic tests. Methods. Study participants were posttreatment female breast cancer survivors (N =163) recruited at a university breast cancer clinic. We assessed their health literacy (using REALM) and their interpretation of hypothetical recurrence risk results from a genomic test, presented in several verbal and numerical formats. Analyses controlled for women's objective recurrence risk, age, income, and race. Results. Women with lower health literacy gave higher mean estimates of recurrence risk for a hypothetical group of women with early-stage breast cancer than did women with higher health literacy (52% v. 30%, P < 0:001). Women with lower health literacy also gave more variable estimates in this and several other tasks. When making chemotherapy decisions using risks presented in verbal formats, decisions by women with lower health literacy were less sensitive to the difference between low and high recurrence risk. Ease of understanding of risk formats differed by health literacy. Conclusions. Health literacy affected the meanings women assigned to recurrence risk when presented in certain formats. The greater variability in responding by women with lower health literacy supports the hypothesis that they have less precise mental representations of risk, but more research is needed to rule out other possible explanations.
- 11 September 2008
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 117 (1) , 25-29
When genomic and standard test results diverge: implications for breast cancer patients’ preference for chemotherapy
Purpose We examined how women incorporate potentially differing genomic and standard assessments of breast cancer recurrence risk into chemotherapy decisions. Methods 165 women previously treated for early-stage breast cancer indicated their interest in chemotherapy regimens to prevent recurrence of breast cancer in response to six hypothetical vignettes that presented breast cancer recurrence risk estimates from standard criteria and a genomic test, some of which were discordant. Results Standard and genomic test results each elicited greater interest in chemotherapy when they indicated high rather than low risk for recurrence (89% vs. 26%, and 87% vs. 22%, respectively, Ps < 0.001). Genomic test results had a larger impact on chemotherapy preferences than standard measures to predict recurrence. Conclusions Some women may be reluctant to forgo chemotherapy when genomic tests indicate low recurrence risk but standard criteria suggest high risk. Additional research including replication of the findings of this small, vignette-based study is needed.
- 11 September 2008
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 117 (1) , 25-29
When genomic and standard test results diverge: implications for breast cancer patients’ preference for chemotherapy
Purpose We examined how women incorporate potentially differing genomic and standard assessments of breast cancer recurrence risk into chemotherapy decisions. Methods 165 women previously treated for early-stage breast cancer indicated their interest in chemotherapy regimens to prevent recurrence of breast cancer in response to six hypothetical vignettes that presented breast cancer recurrence risk estimates from standard criteria and a genomic test, some of which were discordant. Results Standard and genomic test results each elicited greater interest in chemotherapy when they indicated high rather than low risk for recurrence (89% vs. 26%, and 87% vs. 22%, respectively, Ps < 0.001). Genomic test results had a larger impact on chemotherapy preferences than standard measures to predict recurrence. Conclusions Some women may be reluctant to forgo chemotherapy when genomic tests indicate low recurrence risk but standard criteria suggest high risk. Additional research including replication of the findings of this small, vignette-based study is needed.
- 3 April 2007
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 146 (7) , 502-510
Systematic Review: The Long-Term Effects of False-Positive Mammograms
Although abnormal screening mammograms deleteriously affect the psychological well-being of women during the time immediately surrounding the tests, their long-term effects are poorly understood. To characterize the long-term effects of false-positive screening mammograms on the behavior and well-being of women 40 years of age or older. English-language studies from the MEDLINE, Web of Science, EMBASE, CINAHL, PsycINFO, and ERIC databases through August 2006. Studies were identified that examined the effects of false-positive results of routine screening mammography on women's behavior, well-being, or beliefs. Two investigators independently coded study characteristics, quality, and effect sizes. 23 eligible studies (n = 313 967) were identified. A random-effects meta-analysis showed that U.S. women who received false-positive results on screening mammography were more likely to return for routine screening than those who received normal results (risk ratio, 1.07 [95% CI, 1.02 to 1.12]). The effect was not statistically significant among European women (risk ratio, 0.97 [CI, 0.93 to 1.01]), and Canadian women were less likely to return for routine screening because of false-positive results (risk ratio, 0.63 [CI, 0.50 to 0.80]). Women who received false-positive results conducted more frequent breast self-examinations and had higher, but not apparently pathologically elevated, levels of distress and anxiety and thought more about breast cancer than did those with normal results. Correlational study designs, a small number of studies, a lack of clinical validation for many measures, and possible heterogeneity. Some women with false-positive results on mammography may have differences in whether they return for mammography, occurrence of breast self-examinations, and levels of anxiety compared with women with normal results. Future research should examine how false-positive results on mammography affect other outcomes, such as trust and health care use.
- 3 April 2007
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 146 (7) , 502-510
Systematic Review: The Long-Term Effects of False-Positive Mammograms
Although abnormal screening mammograms deleteriously affect the psychological well-being of women during the time immediately surrounding the tests, their long-term effects are poorly understood. To characterize the long-term effects of false-positive screening mammograms on the behavior and well-being of women 40 years of age or older. English-language studies from the MEDLINE, Web of Science, EMBASE, CINAHL, PsycINFO, and ERIC databases through August 2006. Studies were identified that examined the effects of false-positive results of routine screening mammography on women's behavior, well-being, or beliefs. Two investigators independently coded study characteristics, quality, and effect sizes. 23 eligible studies (n = 313 967) were identified. A random-effects meta-analysis showed that U.S. women who received false-positive results on screening mammography were more likely to return for routine screening than those who received normal results (risk ratio, 1.07 [95% CI, 1.02 to 1.12]). The effect was not statistically significant among European women (risk ratio, 0.97 [CI, 0.93 to 1.01]), and Canadian women were less likely to return for routine screening because of false-positive results (risk ratio, 0.63 [CI, 0.50 to 0.80]). Women who received false-positive results conducted more frequent breast self-examinations and had higher, but not apparently pathologically elevated, levels of distress and anxiety and thought more about breast cancer than did those with normal results. Correlational study designs, a small number of studies, a lack of clinical validation for many measures, and possible heterogeneity. Some women with false-positive results on mammography may have differences in whether they return for mammography, occurrence of breast self-examinations, and levels of anxiety compared with women with normal results. Future research should examine how false-positive results on mammography affect other outcomes, such as trust and health care use.